Search results
Will Gilead's Big Veklury Beat Offset A Cancer Drug Miss?
Investor's Business Daily· 9 minutes agoGilead Sciences beat Wall Street's first-quarter sales forecasts Thursday on the back of its Covid...
Gilead posts quarterly loss, revenue rises 5%
Reuters via Yahoo Finance· 5 minutes agoGilead Sciences reported a first-quarter loss on Thursday after taking a $3.9 billion charge for its recent acquisition of liver drug developer CymaBay...
UBS Group Trims Gilead Sciences (NASDAQ:GILD) Target Price to $75.00
ETF DAILY NEWS· 6 days agoGilead Sciences (NASDAQ:GILD – Free Report) had its price objective reduced by UBS Group from $81.00 to $75.00 in a research note issued to investors on ...
Resonant Capital Advisors LLC Invests $219,000 in Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 5 days agoResonant Capital Advisors LLC bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the fourth quarter, according ...
2,525 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Fidelis Capital Partners LLC
ETF DAILY NEWS· 4 days agoFidelis Capital Partners LLC purchased a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the 4th quarter, according to ...
Gilead Sciences’ (GILD) Outperform Rating Reiterated at Oppenheimer
ETF DAILY NEWS· 4 days agoThe brokerage currently has a $105.00 price objective on the biopharmaceutical company’s stock. Truist Financial downgraded shares of Gilead Sciences from ...
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by OLD National Bancorp IN
ETF DAILY NEWS· 2 days agoOLD National Bancorp IN lowered its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.4% during the fourth quarter, according ...
Western Wealth Management LLC Acquires 576 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
ETF DAILY NEWS· 5 days agoWestern Wealth Management LLC raised its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.2% during the fourth quarter, according ...
Gilead Sciences (GILD) Increases Despite Market Slip: Here's What You Need to Know
Zacks via Yahoo Finance· 6 days agoGilead Sciences (GILD) closed at $66.76 in the latest trading session, marking a +0.91% move from...
The Analyst Verdict: Gilead Sciences In The Eyes Of 12 Experts - Gilead Sciences (NASDAQ:GILD)
Benzinga· 6 days agoLoading... Loading... In the last three months, 12 analysts have published ratings on Gilead Sciences GILD , offering a diverse range of perspectives from ...
